Biotech · Private company
Inventiva Pharma
Track this companyFree. Adds Inventiva Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- IVA337Phase 3 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- EmpagliflozinPhase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- IVA337Phase 2 · Non-Alcoholic Steatohepatitis (NASH)ClinicalTrials.gov · fetched Nov 12, 2026
- LanifibranorPhase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Jun 29, 2022ClinicalTrials.gov NCT05232071 · fetched Nov 12, 2026
- A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 19, 2021ClinicalTrials.gov NCT04849728 · fetched Nov 12, 2026
- Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver DiseasePHASE2 · COMPLETED · started Aug 14, 2018ClinicalTrials.gov NCT03459079 · fetched Nov 12, 2026
- Phase 2b Study in NASH to Assess IVA337PHASE2 · COMPLETED · started Feb 7, 2017ClinicalTrials.gov NCT03008070 · fetched Nov 12, 2026